Latest filing published 24 Feb 2026 for Caribou Biosciences, Inc., €1,772. Read the official filing
No signal scores available.
All filings by Tina M. Albertson on record concern Caribou Biosciences, Inc. We count 3 filings; the first trade dates from 20 February 2025 and the latest from 24 February 2026.
Sales make up the whole of the open-market record (1 sale, €1,772). Outside the open market, there are 2 share grants. Since January 2026: no purchases and 1 sale on the market.
On 24 February 2026 came the latest disclosure, an open-market sale for €1,772 in Caribou Biosciences, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations